---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-22-011140"
form_type: "8-K"
ticker: "TDOC"
cik: "0001477449"
company_name: "Teladoc Health, Inc."
filed_at: "2022-07-27T23:59:59+00:00"
generated_at: "2026-06-24T08:07:01.160452+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# Teladoc Health reports Q2 revenue $592M (+18% YoY) but net loss $3.1B on $3.0B goodwill impairment

## Summary
- Revenue $592.4M (+18% YoY); net loss per share $19.22, mainly from $3.0B non-cash goodwill impairment.
- Adjusted EBITDA $46.7M, down 30% YoY from $66.8M.
- CEO Jason Gorevic cited solid results and Primary360 momentum but noted macroeconomic uncertainty.
- Six-month revenue $1.16B (+21% YoY); net loss $9.78B.

## SEC filing metadata
- accession: 0001558370-22-011140
- form_type: 8-K
- ticker: TDOC
- cik: 0001477449
- company_name: Teladoc Health, Inc.
- filed_at: 2022-07-27T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1477449/000155837022011140/0001558370-22-011140-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1477449/000155837022011140/tdoc-20220727x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-22-011140
- JSON: https://secwatch.observer/filing/0001558370-22-011140.json
- Plain text: https://secwatch.observer/filing/0001558370-22-011140.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.